American Healthcare REIT, Inc. (NYSE:AHR) Sees Significant Drop in Short Interest

American Healthcare REIT, Inc. (NYSE:AHR) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 6,370,000 shares, a decline of 16.9% from the February 28th total of 7,670,000 shares. Based on an average daily volume of 1,850,000 shares, the short-interest ratio is presently 3.4 days. Approximately 4.1% of the shares of the stock are short sold.

American Healthcare REIT Trading Down 0.9 %

AHR traded down $0.29 during trading on Thursday, hitting $30.50. 1,046,993 shares of the stock traded hands, compared to its average volume of 1,719,873. The firm has a market capitalization of $4.81 billion, a P/E ratio of -63.54, a price-to-earnings-growth ratio of 1.57 and a beta of 1.42. American Healthcare REIT has a 12-month low of $12.81 and a 12-month high of $31.54. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37. The firm has a 50-day moving average of $29.15 and a 200 day moving average of $27.73.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Monday, March 31st will be issued a dividend of $0.25 per share. The ex-dividend date is Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.28%. American Healthcare REIT’s dividend payout ratio is currently -370.37%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on AHR shares. KeyCorp decreased their price objective on American Healthcare REIT from $35.00 to $34.00 and set an “overweight” rating on the stock in a report on Monday. Citigroup restated an “outperform” rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. Morgan Stanley lifted their target price on shares of American Healthcare REIT from $36.00 to $37.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 25th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of American Healthcare REIT in a research report on Wednesday, March 19th. Finally, JMP Securities set a $35.00 price objective on American Healthcare REIT in a report on Tuesday, March 4th. Seven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, American Healthcare REIT currently has an average rating of “Buy” and an average target price of $33.33.

Institutional Trading of American Healthcare REIT

Several large investors have recently modified their holdings of the business. Franchise Capital Ltd purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $75,000. MassMutual Private Wealth & Trust FSB raised its holdings in shares of American Healthcare REIT by 189.0% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company’s stock valued at $29,000 after acquiring an additional 633 shares in the last quarter. California State Teachers Retirement System lifted its stake in American Healthcare REIT by 3.0% in the fourth quarter. California State Teachers Retirement System now owns 141,984 shares of the company’s stock worth $4,035,000 after acquiring an additional 4,086 shares during the period. Centaurus Financial Inc. bought a new stake in American Healthcare REIT in the fourth quarter valued at $133,000. Finally, Employees Retirement System of Texas bought a new position in American Healthcare REIT in the 4th quarter worth $3,837,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.